182 related articles for article (PubMed ID: 31571913)
1. MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues.
Lu L; Wu M; Lu Y; Zhao Z; Liu T; Fu W; Li W
Onco Targets Ther; 2019; 12():7623-7636. PubMed ID: 31571913
[TBL] [Abstract][Full Text] [Related]
2. Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer.
Jin L; Ma X; Zhang N; Zhang Q; Chen X; Zhang Z; Ding G; Yu H
Cancer Manag Res; 2021; 13():8599-8609. PubMed ID: 34815714
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.
Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K
Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228
[TBL] [Abstract][Full Text] [Related]
4. Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.
Zhou D; Li X; Zhao H; Sun B; Liu A; Han X; Cui Z; Yuan L
J Cell Biochem; 2018 Aug; 119(8):6997-7008. PubMed ID: 29693274
[TBL] [Abstract][Full Text] [Related]
5. Identification of chemoresistance-associated miRNAs in breast cancer.
Lou W; Liu J; Ding B; Xu L; Fan W
Cancer Manag Res; 2018; 10():4747-4757. PubMed ID: 30425571
[TBL] [Abstract][Full Text] [Related]
6. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.
Xie X; Huang N; Zhang Y; Wei X; Gao M; Li M; Ning J; Liu W; Zhao Q; Wang H; Gu K
J Cancer; 2019; 10(4):1039-1051. PubMed ID: 30854110
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
Xue B; Li S; Jin X; Liu L
BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
[TBL] [Abstract][Full Text] [Related]
8. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
Zhou X; Jin W; Jia H; Yan J; Zhang G
J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-3180-3p and miR-124-3p may Function as Noninvasive Biomarkers of Cisplatin Resistance in Gastric Cancer.
Jin L; Zhang Z
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337849
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients.
Jin L; Zhang N; Zhang Q; Ding G; Yang Z; Zhang Z
PeerJ; 2020; 8():e8943. PubMed ID: 32328349
[TBL] [Abstract][Full Text] [Related]
11. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
12. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
13. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J
Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110
[TBL] [Abstract][Full Text] [Related]
15. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y; Zheng Y; Duan Y; Ma L; Nan P
Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
[TBL] [Abstract][Full Text] [Related]
18. miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer.
Wei X; Zhu J; Zhang Y; Zhao Q; Wang H; Gu K
J Cancer; 2021; 12(22):6756-6772. PubMed ID: 34659565
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling.
Ni Q; Zhang Y; Tao R; Li X; Zhu J
Aging (Albany NY); 2021 Mar; 13(6):8665-8687. PubMed ID: 33714198
[TBL] [Abstract][Full Text] [Related]
20. Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis.
Wei C; Gao JJ
PeerJ; 2019; 7():e7882. PubMed ID: 31637133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
